Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.
Rapid Dose Therapeutics Corp. has canceled 5,350,000 stock options previously granted to its employees, advisors, and consultants, due to the options being ineffective as an incentive. The Canadian biotech company plans to regrant an equal number of options at a new exercise price after a 30-day waiting period, aiming to better align interests with the corporation’s goals. Meanwhile, Rapid Dose continues to innovate in drug delivery with their QuickStrip™ product, designed for quick bloodstream absorption of various active ingredients.
For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.
